Aaron Fox-Collis, VP of Finance & CAO at Fresh Tracks Therapeutics, Inc. (FRTX), sold 74 shares at $0.91 ($67) on 2023-12-08, disclosed to the SEC on 2023-12-11.
Open-market sale of $67 FRTX by VP of Finance & CAO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.